GlobeStar Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.002; its P/E ratio is -4.35; GlobeStar Therapeutics is scheduled to report earnings on February 15, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ -163.76K	-	-	-	-
Gross Profit	$ -163.76K	$ -42.23K	-	-	-
EBIT	$ -155.87K	$ -287.79K	$ -1.27M	$ -142.06K	$ -155.24K
EBITDA	$ -150.61K	$ -278.17K	$ -1.26M	$ 0.00	$ -145.90K
Net Income Common Stockholders	$ -295.18K	$ -350.57K	$ -1.28M	$ -150.24K	$ -165.91K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 0.00	$ 0.00	$ 0.00	$ 176.00	$ 7.72K
Total Assets	-	-	-	$ 176.00	$ 10.22K
Total Debt	$ 368.67K	$ 359.71K	$ 15.88K	$ 0.00	$ 20.00K
Net Debt	$ 368.67K	$ 359.71K	$ 15.88K	$ -176.00	$ 12.28K
Total Liabilities	$ 1.53M	$ 1.43M	$ 1.28M	$ 1.29M	$ 1.25M
Stockholders Equity	$ -1.53M	$ -1.43M	$ -1.28M	$ -1.29M	$ -1.24M
Cash Flow	-
Free Cash Flow	$ -42.80K	$ -72.69K	$ -40.18K	-	$ -39.14K
Operating Cash Flow	$ -42.80K	$ -72.69K	$ -40.18K	-	$ -39.14K
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ 42.80K	$ 72.69K	$ 40.00K	-	$ 40.50K

Currency in USD

GlobeStar Therapeutics Earnings and Revenue History

Income Statement >

GlobeStar Therapeutics Debt to Assets

Balance Sheet >

GlobeStar Therapeutics Cash Flow

Cash Flow >

GlobeStar Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing